Metaiodobenzylguanidine and heart rate variability in heart failure

Japanese Circulation Journal

Volumn 62, Issue 10, 1998, Pages 770-772

  Kurata, Chinori ^a   Shouda, Sakae ^a   Mikami, Tadashi ^a   Uehara, Akihiko ^a   Ishikawa, Keiko ^a   Tawarahara, Kei ^b   Nakano, Tomoyasu ^b   Matoh, Fumitaka ^b   Takeuchi, Kazuhiko ^b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hamamatsu Red Cross Hospital   (Japan)

Author keywords

123I metaiodobenzylguanidine; Congestive heart failure; Heart rate variability

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; FEMALE; FOURIER ANALYSIS; HEART RATE VARIABILITY; HUMAN; MALE; SCINTIGRAPHY;

ADULT; AGED; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED;

EID: 0031720129     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.62.770     Document Type: Article

References (9)

1. Task Force of European Society of Cardiology and North American Society of Pacing and Electrophysiology: Heart rate variability: standards and measurement, physiological interpretation, and clinical use. Circulation 1996; 93: 1043-1065
2. 123I-metaiodobenzylguanidine from the heart in patients with chronic renal failure on dialysis. J Nucl Med 1995; 36: 2037-2043
3. Somsen GA, Szabó BM, van Veldhuisen DJ, de Milliano PAR, de Groot CA, Lie KI: Comparison between iodine 123-metaiodobenzylguanidine scintigraphy and heart rate variability for the assessment of cardiac sympathetic activity in mild to moderate heart failure. Am Heart J 1997; 134: 456-458
4. 123I-metaiodobenzylguanidine kinetics with heart rate variability and plasma norepinephrine. J Nucl Cardiol 1997; 4: 515-523
5. Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, et al: Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988; 78: 1192-1199
6. Van de Borne P, Montano N, Pagani M, Oren R, Somers VK: Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 1997; 95: 1449-1454
7. Shiigi T, Furutani Y, Nakamura Y, Nakamura H, Harada M, Yamamoto T, et al: Relative usefulness of measures of heart rate variability and neuroendocrine activity as indicators of autonomic nervous abnormality in patients with left ventricular dysfunction. Jpn Circ J 1998; 62: 336-340
8. Mortara A, La Rovere MT, Signorini MG, Pantaleo P, Pinna G, Martinelli L, et al: Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. Br Heart J 1994; 71: 422-430
9. Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD: Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994; 90: 234-240